Thursday, September 3, 2020
Episode 94 features the best of ASCO 2020, and we'll see you all with new content for episodes 95 and 96.
* * *
- How did it go? Nick Andrews and David Henry, MD, discuss how Dr. Henry thought the meeting went from episode 73.
- Top five abstracts. Dr. Henry and Alan Lyss, MD, discuss their top five abstracts each from episode 74.
- Preview/review. Howard "Skip" Burris, III, MD, joined Dr. Henry to talk about how ASCO was changing amid the COVID-19 pandemic from episode 68.
* * *
Email the show: [email protected]
Follow us on Twitter: @MDedgeHemOnc
Follow Dr. Henry on Twitter: @DavidHenryMD
@davidhenrymd. Dr. Henry reported being on the advisory board for Amgen, AMAG Pharmaceuticals, and Pharmacosmos. He reported institutional funding from the National Institutes of Health and FibroGen.